Table 2:
Anticancer Small Molecule | Source of Exosomes | Model System | Drug Load* | Reference |
---|---|---|---|---|
| ||||
Anthocyanidins | Raw bovine milk |
In vitro ovarian cancer cell lines In vivo ovarian cancer in mice |
~20% | [136] |
Raw bovine milk |
In vitro lung, prostate, colon, breast, pancreatic, and ovarian cancer In vivo lung cancer xenografts in mice |
~20% | [137] | |
Raw bovine milk | In vivo colon cancer in mice | ~20% | [138] | |
| ||||
Celastrol | Raw bovine milk |
In vitro lung cancer cell lines In vivo lung cancer xenografts in mice |
18–20% | [139] |
| ||||
Curcumin | Raw bovine milk |
In vitro breast, lung, and cervical cancer cell lines In vivo cervical tumor xenografts |
18–24% | [135] |
Raw bovine milk | In vitro breast cancer cell lines | 2 μM | [116] | |
Pasteurized skim milk | In vitro colorectal cancer cell lines | 9% | [140] | |
| ||||
Raw Bovine Milk | In vitro breast cancer cell lines | EE ~70% | [141] | |
Doxorubicin | Raw Bovine Milk | In vitro breast and lung cancer cell lines | None reported | [142] |
Raw Bovine Milk | In vitro and in vivo oral squamous cell carcinoma | 13.4% | [143] | |
| ||||
Paclitaxel | Raw bovine milk | In vitro lung cancer cells | ~8% | [81] |
Raw bovine milk | In vitro breast cancer cell lines | ~30% | [144] | |
Bovine colostrum |
In vitro lung cancer cell lines In vivo lung cancer in mice |
25–75% | [145] | |
| ||||
Resveratrol | Raw bovine milk | In vitro breast cancer cell lines | 15 M | [116] |
| ||||
Withaferin | Raw bovine milk |
In vitro lung cancer lung cancer tumors in mice |
[81] |
Reported as w/w percent drug load unless otherwise indicated. EE = encapsulation efficiency.